MedStar Southern Maryland Hospital Center Premieres Halcyon™ Cancer Treatment, Becomes First Center with this New Technology in DC/Metro Area

CLINTON, MD—MedStar Southern Maryland Hospital Center (MSMHC)’s new cancer treatment center is one step closer toward its completion with the addition of a new cancer-fighting technology in the office of Radiation Oncologist Andrew Satinsky, MD

On March 20, Dr. Satinsky began using the new Halcyon™ machine to treat patients. The Halcyon™ is an image guidance system delivering radiation more easily, more efficiently and with greater comfort, without compromising on quality. This results in a treatment that is highly effective in far less time.

Dr. Satinsky treating a patient with the Halcyon™ machine.

“This treatment revolutionizes the quality, expediency, comfort and safety of patients treated with radiation in the state of Maryland,” said Andrew Satinsky, MD. “This is exciting for us because we’re the first center in the DC Metro area to have this, and it means we’re on the cutting edge of technology.”

This new technology involves a low energy X-ray that allows soft imaging of the patient to minimize radiation risks while delivering afterwards a powerful treatment capable of achieving the demands of each patient’s needs. Another advantage includes new software tools that allow clinical evaluations for quick decision making on the need for clinical changes to the treatment, through adaptive radiation therapy.

The first patient to be treated at MSMHC was U.S. Department of Behavioral Health Police Officer John Long, who is receiving this treatment five days per week for two months.

“The process was simpler than I thought,” said Long. “It takes just ten to twelve minutes and they have explained everything to me, really taken the time to explain the process.  I came here because my first impression was good and I haven’t been disappointed.”

Already, MSMHC has expanded its cancer treatment services to include a robust Cancer Committee, which meets throughout the year to discuss the latest innovations in cancer patient care.  It also has a weekly tumor board meeting where a team of physicians in different disciplines meet to confer on cases.  In addition, the hospital’s roster of cancer treatment physicians, which includes Andrew Satinsky, MD, and Breast Surgeon Ekaterina Tsiapali, MD, recently expanded to add Hematologist-Oncologist Eric Rubenstein, MD.

“The acquisition of the Halcyon™ machine is another step toward offering the most state-of-the-art medicine and creating the new cancer treatment center we are building at MedStar Southern Maryland Hospital Center,” said MSMHC President Christine Wray.

This fall, MSMHC plans to open its cancer treatment center. This center will serve as a connector between all disciplines involved in cancer treatment, from the patient to radiation oncologists, nursing, social workers, surgeons, specialists and primary care doctors, allowing the team to tailor care to the individual patient’s needs while collaborating with all care providers, and taking an approach that involves cooperation between everyone involved in a patient’s treatment. The second advantage of this center will be to offer state-of-the-art care close to the residents of southern Maryland.

“The key is to let patients stay near home, in their community, not have to struggle to get to a reputable cancer center.  We know there are physical limitations associated with a cancer diagnosis and the ideal place to heal is at home under the careful watch of family, friends and community,” said Dr. Rubenstein.

For more information about cancer treatment at MedStar Southern Maryland Hospital Center, please visit


About MedStar Southern Maryland Hospital Center:

MedStar Southern Maryland Hospital Center, located in Clinton, Maryland, is a 176 bed acute care hospital serving the Washington, D.C., metro and Southern Maryland area. The hospital is focused on caring for patients and their loved ones utilizing advanced technology under the guidance of expert clinicians. Quality, Safety, Wellness, and Patient Satisfaction are achieved through a spirit of patient centered services that connect us to the community we serve.

For more information, visit


Media Contact

Cheryl Richardson

SiTEL Mock Drills Hone Skills, Help Craft Policy

When Perinatal Nurse Educator Lisa Hulvey, MSN, RNC-OB, C-EFM, comes up with an idea for an educational exercise that can reaffirm best practice or help the team identify ways to improve current practice, she contacts the MedStar Simulation Training & Education Lab (SiTEL) team to design and implement a drill. 

Hulvey also works with the MedStar Obstetrical Simulation Team (MOST), which is affiliated with SiTEL, to develop quarterly obstetrical drills, such as a Code Stork scenario where a birth is taking place outside of Labor and Delivery. 

These drills help to evaluate aspects of practice such as teamwork, available resources, and response times.  The drills conclude with a de-briefing meeting to discuss the exercise, which Hulvey says is the most important aspect of the drill.

“This is one of the great benefits of being a part of MedStar,” says Hulvey.  “SiTEL has always been there for me, taking my vision and creating realistic scenarios, using both mannequins and actors, and running the drills really well, so participants can see a realistic scenario and process through what we’re supposed to do.”

Hulvey says that not only do the drills help improve care, they have also been used to craft policy when they are run during the development phase of hospital policy.

Cheryl Camacho, NRP, Manager, EMS Certifications & Programs, Clinical Education & Experiential Learning with SiTEL, also works with MedStar Southern Maryland on other drills, such as Code Blue, or Cardiac Arrest drills, which also measure skill and response times.

“We look at timed responses,” says Camacho.  “How quickly was CPR started?  Was the first drug administered within five minutes?  And overall, we look at teamwork and communication.”

How Genetic Counseling is Empowering Those at Risk for Inherited Cancers


For all that we still don’t know about cancer, we are certain of two facts:

  • Five to ten percent of cancers—including some breast, ovarian, endometrial, colon, thyroid, and pancreatic cancers—are due to an inherited gene mutation, and
  • The earlier you catch cancer, the easier it is to treat.

The goal of genetic testing is to identify genetic abnormalities, called gene mutations, which increase an individual’s risk to develop certain cancers. But who should get tested? Does a positive result guarantee that you’ll get cancer? And does a negative result ensure that no future screening is necessary?

This is where genetic counseling comes in. Genetic counseling is a comprehensive approach to assessing and managing an individual’s cancer risk. Genetic counselors help patients understand how mutations contribute to cancer risk and can be passed down through families; who can benefit from testing; how test results are interpreted; the probability that an individual will develop cancer or a secondary cancer; the likelihood of relatives inheriting the mutation; and appropriate screening and risk-reduction strategies, and also provides resources for support.

Chloe Farkas, MGC, CGC is a certified genetic counselor, based at the Lombardi Comprehensive Cancer Center at MedStar Georgetown University Hospital. She also sees patients at MedStar Southern Maryland Hospital Center’s Breast Health Program and the Washington Cancer Institute at MedStar Washington Hospital Center.

“I feel strongly about making medical and scientific information available to everyone,” Chloe says. “Genetics is an emerging science and it is changing rapidly. Something new is discovered almost every week.”

In the general population, the risk of having a gene mutation associated with a hereditary cancer syndrome is low. But if you have a family history of early-onset and/or rare cancer, were diagnosed with cancer before the age of 50, or have a known mutation in a cancer risk gene such as BRCA1 or BRCA2 in your family, you are a candidate for genetic testing.

Chloe’s job starts before the testing begins. “I provide information and context for the patient,” she says. “After we talk, some patients choose to have genetic testing and some don’t. For most individuals at high risk to carry a mutation, we encourage testing because a positive result may inform options for increased cancer screening and/or risk reducing surgeries. Individuals at high risk to carry a mutation are generally patients who have been diagnosed with a cancer suggestive of a hereditary cancer syndrome (i.e. an individual diagnosed with breast cancer diagnosed before age 50) or it may be a person who has not developed cancer, but whose relative carries a known genetic mutation.  We try not to test individuals without a personal history of cancer who do not have a known genetic mutation in the family because it is much harder to interpret the meaning of a negative result and because it is difficult to obtain insurance coverage for genetic testing for unaffected individuals.”

It all starts with the genes. Genes tell our bodies how to function and develop. We all have two copies of each gene; one copy inherited from mom and one copy inherited from dad. A small percentage of people are born with an inherited gene mutation in a cancer risk gene, which means they have only one working copy of that gene. Because specific cancer risk genes prevent the growth of tumors or the development of cancers, people with only one working gene are not as well protected as those with two working copies of the gene, putting them at higher risk to develop cancer.

So the first step for a genetic counselor is to gather the patient’s medical and family histories, which will indicate the probability that she or he may have a mutation in a cancer risk gene. If a patient does not have cancer, Chloe assesses his or her risk of carrying a gene mutation, helps identify the best candidate in the family to undergo genetic testing, and estimates an individual’s cancer risk based on the patient’s personal and family history using risk modeling. If there is a personal history of cancer, Chloe explains possible inherited causes of the cancer and assesses the risk that the patient may develop a secondary cancer. She then helps the patient decide whether genetic testing is appropriate and whether he or she wants to pursue it.

Genetic tests are more affordable and accessible than ever before. Inherited breast and ovarian cancers are primarily caused by mutations in two genes: BRCA1 and BRCA2; Chloe provides genetic testing for those and others that are not as common.

Results are available within two to six weeks, depending on the test, and Chloe then contacts the patient to discuss the result and answer questions.

“Genetic counseling helps patients put all this information in perspective, because the details can be confusing or scary at first,” she says.

Although genetic testing accurately detects the vast majority of known mutations, no test can be 100% accurate. An individual may still carry an undetected mutation, even with a negative result; patients who are at risk based on personal and/or family history are encouraged to have regular cancer screenings to ensure that if a cancer does develop, it’s caught early. Conversely, receiving a positive result does not guarantee a person has an 100% chance to develop cancer. Genetic counselors help patients and their physicians understand the meaning of a genetic testing result.  Physicians and patients can then use the information to appropriately tailor a cancer screening program.

Chloe’s interest in genetics started in college, and eventually drew her into the healthcare field. She earned a B.A. degree in chemistry and English from Case Western Reserve University, and a master’s in genetic counseling from the University of Maryland. She is one of only two cancer genetic counselors in the MedStar system in the Washington, D.C. area.

“We’re very excited to have Chloe here at MedStar Southern Maryland Hospital,” says Katerina Tsiapali, MD, a surgical oncologist and medical director of the MedStar Breast Health Program. “With genetic counseling, patients are educated and given context in which to understand the test results, so they’re prepared for all eventualities.”

Chloe Farkas, MGC, CGC


MedStar’s New Website Is A One-Stop Resource For Accessing Doctors and Trusted Healthcare Information

Columbia, MD – MedStar Health’s newly integrated website——launches Monday, Oct. 21. It brings together 16 external websites into one system site, giving visitors easier access to physicians and services across MedStar Health. Now, consumers will have a single online destination for trusted healthcare information.

“True to our Patient First value, the new website was created with the end-user—our patients, families, job seekers, clinicians, associates, and consumers—in mind, creating a seamless experience focused entirely on the needs of the communities we serve. The website not only reflects the depth and breadth of services offered throughout and across MedStar Health, but it represents the strength of systemness in action,” says President and CEO Kenneth A. Samet, FACHE.

At, visitors can:
•  Search for any MedStar physician with one easy-to-use tool, Find a Doctor, which is accessible
on every page
•  Register for any MedStar class or program
•  Find information on all services offered at MedStar
•  Search the enhanced health encyclopedia for health topics from A to Z

Detailed service line content, like cancer, heart and orthopaedic care, is consolidated and updated with links to entity-specific information. Individual hospitals and other MedStar entities have their own subsites within the system site, and familiar sections have been updated, such as Patients and Visitors, About Us, Giving, and Careers.

About MedStar Health

MedStar Health combines the best aspects of academic medicine, research and innovation with a complete spectrum of clinical services to advance patient care. As the largest healthcare provider in Maryland and the Washington, D.C., region, MedStar’s 10 hospitals, the MedStar Health Research Institute and a comprehensive scope of health-related organizations are recognized regionally and nationally for excellence in medical care. MedStar has one of the largest graduate medical education programs in the country, training more than 1,100 medical residents annually, and is the medical education and clinical partner of Georgetown University. MedStar Health is a $4.5 billion not-for-profit, regional healthcare system based in Columbia, Maryland, and one of the largest employers in the region. Our almost 30,000 associates and 6,000 affiliated physicians all support MedStar Health’s Patient First philosophy that combines care, compassion and clinical excellence with an emphasis on customer service. For more information, visit

Media Contact

Ann C. Nickels
[email protected]
Phone: 410-772-6661